Zhili Yao, PhD profile page

Dr. Zhili Yao is the Director of the In Vivo Pharmacology Group in WuXi Biologics’ CRO Services Department. He earned his degree from the Department of Chemistry and Biochemistry at Ohio State University, followed by three years of training as immunologist at the Wexner Medical Center. With over 10 years’ experience in macromolecular PK/PD/Tox platforms and oncology & autoimmune disease models, Dr. Yao played a key role in establishing the NHP toxicokinetics platform and the murine antibody biodistribution platform. Dr. Yao has also led the in vivo studies for multiple key IND projects, several of which have successfully advanced to the clinical stage.